Flagship Harbor Advisors LLC Has $570,000 Holdings in SPDR S&P Biotech ETF (XBI)

Flagship Harbor Advisors LLC raised its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.5% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 6,296 shares of the exchange traded fund’s stock after acquiring an additional 329 shares during the period. Flagship Harbor Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $570,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Cranbrook Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF in the 4th quarter valued at $26,000. Gradient Investments LLC acquired a new position in SPDR S&P Biotech ETF in the 1st quarter valued at $27,000. Truewealth LLC acquired a new position in SPDR S&P Biotech ETF in the 4th quarter valued at $29,000. Quattro Financial Advisors LLC raised its holdings in SPDR S&P Biotech ETF by 49.6% in the 4th quarter. Quattro Financial Advisors LLC now owns 374 shares of the exchange traded fund’s stock valued at $31,000 after acquiring an additional 124 shares during the last quarter. Finally, Lehman & Derafelo Financial Resources LLC acquired a new position in SPDR S&P Biotech ETF in the 4th quarter valued at $32,000.

Shares of XBI opened at $88.99 on Wednesday. SPDR S&P Biotech ETF has a fifty-two week low of $64.38 and a fifty-two week high of $101.55.

COPYRIGHT VIOLATION NOTICE: “Flagship Harbor Advisors LLC Has $570,000 Holdings in SPDR S&P Biotech ETF (XBI)” was originally published by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are viewing this story on another publication, it was illegally copied and republished in violation of US & international trademark & copyright law. The original version of this story can be read at https://www.thelincolnianonline.com/2019/04/17/flagship-harbor-advisors-llc-has-570000-holdings-in-spdr-sp-biotech-etf-xbi.html.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Further Reading: What are Institutional Investors?

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.